
Biobeat
Biobeat makes a wireless chest patch that monitors blood pressure continuously without a cuff, aiming to improve hypertension diagnosis and treatment. The company has raised $58M and employs 78 people.
The growth story

Biobeat grew from 28 to 78 employees between 2021 and 2026, raising $58M along the way, most recently a Series B in December 2025.
About
Biobeat sells a medical device that tracks blood pressure 24/7 using a chest patch, eliminating the need for traditional cuffs. The FDA-cleared system combines this data with patient-reported symptoms to help clinicians personalize treatment plans.
The company has raised $58M, most recently in a Series B round led by prominent healthcare investors. With 78 employees, Biobeat draws heavily on talent from major medical device firms like Axonics and Boston Scientific.
Founders and leadership
Sales is Biobeat's largest department with 14 staff. The company has a median tenure of 4 years, suggesting stable leadership and organizational structure.












The Biobeat org chart
Arik B. (Co-Founder and CEO) leads 34 mapped leaders with 5 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew

Headcount by function: Sales 17 (+183% YoY), Engineering 12 (-8% YoY), Business Development 8 (+60% YoY), Marketing 6 (+100% YoY), Research 4 (+33% YoY), Quality Assurance 3 (+50% YoY).
Talent flow
Biobeat recruits heavily from medical device leaders, with Axonics (23 hires) and Boston Scientific (12) being top sources. Employees often move to healthcare startups or return to major hospitals.

Most common previous employers of Biobeat staff: Axonics (23), Boston Scientific (12), Medtronic (6), Abbott (5), Stryker (4), Israel Defense Forces (4). Former Biobeat employees most often moved to abra (2), QuantHealth (2), Hadassah Medical Center (2), My Health Economics (1), TavTech (1), Deeplica AI (1).
Alumni worth knowing
Web traffic

Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of

Most common skills at Biobeat: Medical Devices (36), Leadership (29), Sales (21), Management (20), Customer Service (20), Communication (19), Healthcare (18), Product Launch (16).
Where the team actually sits

Biobeat people are concentrated in Israel (14), Tel Aviv District, Israel (6), Center District, Israel (5), Florida, United States (3).
Search footprint
Biobeat attracts about 432 organic search visits a month, traffic worth roughly $3K a month if bought through ads. It gained 111 ranking keywords and lost 95 in the last period.
What employees say
- Compensation
- 4.30 / 5
- Career opportunities
- 3.90 / 5
- Senior management
- 4.20 / 5
- Work-life balance
- 3.60 / 5
Frequently asked
Biobeat has 78 employees as of September 2026.
Biobeat has raised $58M in total, most recently a Series B round in December 2025.
Biobeat was founded in 2016 by Arik B., Johanan May, Israel Sarussi.
Arik B. (Co-Founder and CEO) sits at the top of Biobeat's reporting structure, with 5 direct reports.
The most common previous employers of current Biobeat staff are Axonics (23 people), Boston Scientific (12 people), Medtronic (6 people).
Former Biobeat employees most often move to abra (2), QuantHealth (2), Hadassah Medical Center (2).
Biobeat attracts about 432 organic search visits a month, worth roughly $3K a month in equivalent ad spend.
The most common skills among Biobeat staff are Medical Devices, Leadership, Sales, Management, Customer Service.
Biobeat staff are concentrated in Israel (14), Tel Aviv District, Israel (6), Center District, Israel (5).
Biobeat has about 17 people in Sales, up 183% over the past year, as of September 2026.
Biobeat has about 12 people in Engineering, down 8% over the past year, as of September 2026.
Computed from 63 current and 48 former Biobeat profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.




